There have been several case reports of muscle abnormalities following mechanical ventilation for acute asthma'·4. We report an unusually severe case of rhabdomyolysis and renal failure in a young female patient with life-threatening asthma, who on investigation had a necrotizing myopathy. The cause remains uncertain.
CASE REPORT
A 38-year-old woman presented to the Accident and Emergency (A&E) department in severe respiratory distress. She was obtunded, cyanosed and unable to speak. Past history included three intensive care unit (ICU) admissions with severe asthma, twice requiring artificial ventilation. Her normal medication comprised salbutamol inhaler as required, beclomethasone dipropionate inhaler 200 p.g twice daily and aminophylline tablets 225 mg twice daily. No other medications had been given prior to arrival in the A&E department. On arrival she was treated with nebulized terbutaline 10 mg, intravenous hydrocortisone 200 mg and an intravenous infusion of salbutamol 10 p.g/min. Initially her level of consciousness improved but she became increasingly tachypnoeic and distressed, and within 60 minutes of her arrival endotracheal intubation was performed under ketamine 70 mg and suxamethonium 100 mg. Arterial blood gases were as follows: pH 7.07, Pa0 2 14.3 kPa, P a C0 2 10.3 kPa, bicarbonate 22 mmolll, base excess -8, breathing 60070 oxygen on arrival, and pH 7.16, P a 0 2 17.7 kPa, P a C0 2 7.95, bicarbonate 22 mmolll, base excess -8, breathing 60% oxygen following institution of mechanical ventilation. She was admitted to the ICU where salbutamol15 p.g/min by infusion and nebuliser 5 mg four hourly and intravenous hydrocortisone 100 mg six hourly were continued in addition to intermittent positive pressure ventilation. Pethidine and midazolam infusions were commenced for sedation. Admission investigations are summarized in Table I .
Bronchospasm continued to be a major problem and muscle paralysis with a vecuronium infusion 4 mg/hr was instituted the next day. Pethidine was discontinued and an infusion of ketamine substituted. She became pyrexic with no focal signs of infection, and intravenous erythromycin was commenced. Cefuroxime was added on day 3 as non-lactose fermenting coliforms were identified in tracheal aspirate. She also received subcutaneous heparin and intravenous ranitidine as prophylaxis against venous thrombosis and stress ulceration respectively.
An aminophylline infusion was commenced on day 4. Antibiotics were changed to ciprofloxacin on day 7. Rectal temperature peaked at 39.8°C on day 9 and 40.3°C on day 10. Reduced evidence of bronchospasm permitted ketamine and vecuronium to be discontinued on days 10 and 11 respectively, and pethidine was restarted. The total dose of vecuronium administered was 860 mg over nine days. Sedatives were stopped and she was weaned from ventilation and extubated on day 12. She failed to cope, however, due to poor respiratory effort rather than a recurrence of bronchospasm, and required reintubation, for which etomidate 12 mg and suxamethonium 100 mg were given. Her fever peaked again at 40.9°C soon after reintubation. Pethidine and midazolam infusions were recommenced for sedation. A percutaneous dilatational tracheostomy was performed under ketamine 25 mg and vecuronium 10 mg.
Plasma creatinine was noted to have risen from 90 mmoUl to 125 mmoUI on day 13, but urine output continued at > 90 mUh. By day 15 her general condition had not improved; she was generally weak and plasma creatinine level was now 200 mmoUl with a falling urine output. Imipenem was prescribed to replace ciprofloxacin. Further biochemical investigation revealed a plasma creatine kinase activity greater than 26,000 IU/l. Urine was positive for myoglobin, although this was not quantified. In an attempt to increase renal perfusion, intravenous fluids were increased and a Iow-dose dopamine infusion commenced. Despite these manoeuvres there was continuing decline in urine output, with rising plasma concentrations of urea and creatinine. She was commenced on continuous veno-venous haemodiafiltration (CVVHDF) on day 19.
Blood gases, biochemistry, drug infusions and duration of IPPV
Further investigations were performed in an attempt to determine the cause of rhabdomyolysis and these are summarized in Table 2 . A muscle biopsy performed under local anaesthesia showed an acute necrotizing myopathy ( Figure 1 ). There were numerous swollen necrotic fibres with occasional vacuolated degenerated fibres and some basophilic regenerating fibres. Focal myophagocytosis was present but there was no other inflammation. A biopsy repeated a few days later showed the same appearances but with more regenerating fibres. Enzyme histochemistry showed many moth-eaten and whorled fibres. There were no ragged-red fibres and no excess of glycogen. Electron microscopy confirmed the presence of necrotic myofibres with myofibrillar disruption and abundant phagolysosomes. She developed a profound global muscle weakness and required ventilatory support for a further 29 days. Bronchospasm was not a continuing problem and all bronchodilator infusions were discontinued by day 18. Hydrocortisone dose was reduced to 100 mg three times daily from day 16 and discontinued on day 21. Renal support with CVVHDF was provided until day 29; following this she passed adequate urine volumes without support.
On the 53rd day following admission she was deemed fit for discharge from rCv. She was able to sit unsupported and to raise a glass to her mouth, but was not able to raise her arms above her head or raise her legs off the bed. Plasma creatinine concentration had settled at 117 mmolll, and her daily urine output was satisfactory. Neurophysiological studies were performed 15 days later. A mild sensory neuropathy was demonstrated. There was no motor abnormality but electromyograph studies were consistent with a myopathy. 
DISCUSSION
Prolonged weakness following ventilation for acute asthma is well described and has been attributed to the use of high doses of steroids,·2, to a neurogenic causel, to rhabdomyolys is' and to the use of muscle relaxants'. We report a further case of rhabdomyolys is in association with acute asthma which demonstrates an unusual pattern of histological and neurophysiological features. Rhabdomyoly sis has been described following a number of different insults including crush injuries, acute limb ischaemia, prolonged immobilization and major trauma 6 • More recently rhabdomyolysi s and consequent raised plasma creatine kinase activity has been described in patients with sepsis'. Rhabdomyolysis has also been previously reported in association with acute severe asthma 4 • s , and the hypothesis advanced that it may be due to respiratory muscle fatigue, generalized muscle hypoxia or a combination of both.
This case most closely resembles those reported by Barrett and colleagues'. In their three cases, the diagnosis of rhabdomyolys is was made on raised creatine kinase activity and presence of myo-Anaesthesia and Intensive Care. VD!. 22, No. 6, December, 199-1 globinuria. None of their patients had muscle biopsy or nerve conduction studies. The clinical features and muscle biopsy findings in our patient suggest that muscle damage was generalized, but do not define aetiology.
Various classes of drugs used in this patient have been reported to cause rhabdomyolys is. A toxicology screen performed on an admission blood sample failed to demonstrate significant levels of any agent implicated. Theophylline levels were never higher than the upper limit of the therapeutic range", Terbutaline, however, may be associated with elevated creatine kinase activity in therapeutic doses and has been reported to cause rhabdomyolys is in overdose 10.11 , It is also possible that suxamethoniu m used to facilitate intubation of the trachea caused rhabdomyolys is 12 , This type of myopathy is often associated with hypokalaemia and it is possible that the (32 agonist therapy together with the hydrocortison e contributed to intracellular hypokalaemia , although this was never demonstrated (Table I) ,
Raised levels of creatine kinase may occur in the acute steroid myopathy seen in association with severe asthma, but this is not a constant feature and levels may be normal '. Corticosteroid myopathy is typically associated with a vacuolar myopathy". While there were occasional vacuolated fibres in the first biopsy from our patient, the striking feature was the acute and severe myofibre necrosis. The vacuoles seen in this case were clearly a result of accumulated phagolysosomes in the degenerating fibres and differ from that due to the glycogen accumulation of acute hydrocortisone myopathy with vacuoles.
Interestingly, our patient had a significant metabolic acidosis at initial presentation and the plasma creatine kinase activity was elevated. There was no history to suggest that she had received parenteral i3ragonists prior to admission to cause lactate generation within muscle. We assume that the acidosis was caused by hypoxaemia as the patient was cyanosed and cerebrally obtunded. Arterial blood gases were not performed prior to institution of oxygen therapy and following this hypoxaemia was not demonstrated. The onset of rhabdomyolysis between 9 and 13 days later seems unlikely to be due to preadmission hypoxaemia. We wondered whether a viral infection might have precipitated both a myositis and acute severe asthma. We were not able to demonstrate a viral infection (Table 2 ) and the muscle biopsy appearances were not typical of primary myositis. There was no evidence of underlying metabolic myopathy.
A denervating syndrome has recently been described in severe airflow limitation'. However, in this case the principal neurophysiological features were of sensory rather than motor involvement.
It is now well recognized that muscle weakness is a not uncommon feature of critical illness. A "critical illness neuropathy" has been described which is associated with electromyographic features of an axonal-type (non-demyelinating) neuropathy and atrophy of types 1 and 2 fibres on muscle biopsy l3. The histological features of our patient's biopsy suggest that the critical illness neuropathy was not a cause of the weakness 14
•
Muscle relaxants may cause prolonged weakness in critically ill patients". It is difficult to postulate a mechanism by which neuromuscular blocking drugs could cause the necrotizing myopathy seen here.
The muscle weakness resolved slowly but the cause remains elusive. There is a growing awareness of the variety of causes of weakness that may follow critical illness ranging from persistent neuromuscular blockade" to denervation' and a variety of disorders of nerve and muscle". The clinical picture, together with the muscle biopsy appearances suggest that this is yet another cause of prolonged weakness after critical illness.
